SAGE

Sage Therapeutics
SAGE

Overview Fund Activity
Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

267 hedge funds and large institutions have $8.95B invested in Sage Therapeutics in 2019 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 132 increasing their positions, 59 reducing their positions, and 35 closing their positions.

Holders
267
Holders Change
+19
Holders Change %
+7.66%
% of All Funds
5.79%
Holding in Top 10
10
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+66.67%
% of All Funds
0.22%
New
55
Increased
132
Reduced
59
Closed
35
Calls
$177M
Puts
$98.9M
Net Calls
+$78.3M
Net Calls Change
+$42.5M

Top Buyers

1
Jennison Associates
1
Jennison Associates
New York
$375M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$265M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$1.21B
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$726M
5
TCM
5
TimesSquare Capital Management
New York
$78.8M

Top Sellers

1
Bank of New York Mellon
1
Bank of New York Mellon
New York
$233M
2
PHS
2
PFM Health Sciences
California
$27M
3
Russell Investments Group
3
Russell Investments Group
United Kingdom
$365K
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$0
5
EAM
5
Eventide Asset Management
Massachusetts
$128M
Name Market Value Shares Shares
Change 		Shares
Change %
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$1.32B 8,313,715 +293,304 +4%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$1.21B 7,608,239 +575,163 +8%
Vanguard Group
3
Vanguard Group
Pennsylvania
$726M 4,565,699 +543,229 +14%
BlackRock
4
BlackRock
New York
$425M 2,673,467 +162,976 +6%
Jennison Associates
5
Jennison Associates
New York
$375M 2,355,614 +1,509,950 +179%
Wellington Management Group
6
Wellington Management Group
Massachusetts
$351M 2,207,361 +285,526 +15%
Janus Henderson Group
7
Janus Henderson Group
United Kingdom
$265M 1,668,629 +1,359,947 +441%
Bank of New York Mellon
8
Bank of New York Mellon
New York
$233M 1,462,625 -368,812 -20%
O
9
OppenheimerFunds
New York
$230M 1,443,145 +4,721 +0.3%
BB
10
BB Biotech
Switzerland
$219M 1,375,229 – –
Franklin Resources
11
Franklin Resources
California
$167M 1,049,164 +6,209 +0.6%
State Street
12
State Street
Massachusetts
$166M 1,046,444 -14,390 -1%
JPMorgan Chase & Co
13
JPMorgan Chase & Co
New York
$151M 952,068 +526 +0.1%
PAI
14
Palo Alto Investors
California
$136M 857,681 +6,704 +0.8%
EAM
15
Eventide Asset Management
Massachusetts
$128M 805,000 -131,000 -14%
Invesco
16
Invesco
Georgia
$108M 680,244 +45,095 +7%
Lord, Abbett & Co
17
Lord, Abbett & Co
New Jersey
$98.7M 620,668 +492,910 +386%
FCM
18
Farallon Capital Management
California
$95.4M 600,000 +200,000 +50%
American Century Companies
19
American Century Companies
Missouri
$90.6M 569,930 +39,835 +8%
Artisan Partners
20
Artisan Partners
Wisconsin
$89.4M 562,278 +311,847 +125%
MWNA
21
Marshall Wace North America
New York
$86M 540,408 +53,704 +11%
EAM
22
Eagle Asset Management
Florida
$85.2M 535,672 -111,670 -17%
Geode Capital Management
23
Geode Capital Management
Massachusetts
$83.5M 524,786 +56,869 +12%
TCM
24
TimesSquare Capital Management
New York
$78.8M 495,200 +495,200 New
AllianceBernstein
25
AllianceBernstein
Tennessee
$71.1M 447,072 -24,457 -5%
1
2 3 4 5